Emory University School of Medicine Emory University (12) — Atlanta, Georgia

Emory University School of Medicine Emory University (12) is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Emory University School of Medicine Emory University (12) has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Emory University School of Medicine Emory University (12)?

Emory University School of Medicine Emory University (12) has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Emory University School of Medicine Emory University (12) conducted?

Emory University School of Medicine Emory University (12) has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Is Emory University School of Medicine Emory University (12) accredited by Crixeo Health?

Emory University School of Medicine Emory University (12) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Emory University School of Medicine Emory University (12)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.